Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration

被引:282
作者
Huang, YC
Kaigler, D
Rice, KG
Krebsbach, PH
Mooney, DJ
机构
[1] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA
[3] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA
[4] Univ Michigan, Dept Oral Med Pathol & Oncol, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA
关键词
vascular endothelial growth factor; BMP-4; gene therapy; bone marrow stromal cell; poly(ethylenimine); poly(lactic-co-glycolic acid);
D O I
10.1359/JBMR.041226
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bone formation is a coordinated process involving various biological factors. We have developed a scaffold system capable of sustained and localized presentation of osteogenic (BMP-4) and angiogenic (VEGF) growth factors and human bone marrow stromal cells to promote bone formation at an ectopic site. Combined delivery of these factors significantly enhanced bone formation compared with other conditions. Introduction: Tissue regeneration entails complex interactions between multiple signals and materials platforms. Orchestrating the presentation of these signals may greatly enhance the regeneration of lost tissue mass. Bone formation, for example, is dependent on the signaling of BMPs, molecules initiating vascularization (e.g., vascular endothelial growth factor [VEGF]), and osteogenic precursor cells capable of responding to these cues and forming bone tissue. It was hypothesized that combined and concerted delivery of these factors from biodegradable scaffolds would lead to enhanced bone formation. Materials and Methods: Poly(lactic-co-glycolic acid) scaffolds containing combinations of condensed plasmid DNA encoding for BMP-4, VEGF, and human bone marrow stromal cells (hBMSCs) were implanted into the subcutaneous tissue of SCID mice. Implants (n = 6) were retrieved at 3, 8, and 15 weeks after implantation. Bone and blood vessel formation was determined qualitatively and quantitatively by methods including histology, immmunostaining, and mu CT. Results: Scaffolds delivering VEGF resulted in a prominent increase in blood vessel formation relative to the conditions without VEGF. BMP-4 expression in scaffolds encapsulating condensed DNA was also confirmed at the 15-week time-point, showing the characteristic of long-term delivery in this system. Combined delivery of all three types of factors resulted in a significant increase in the quantity of regenerated bone compared with any factor alone or any two factors combined, as measured with DXA, X-ray, and histomorphometric analysis. Furthermore, bone formed with all three factors had elastic moduli significantly higher than any other condition. Conclusions: Concerted delivery of BMP-4, VEGF., and hBMSCs promoted greater bone formation relative to any single factor or combination of two factors. Materials systems that allows multifactorial presentation more closely mimic natural developmental processes, and these results may have important implications for bone regeneration therapeutics.
引用
收藏
页码:848 / 857
页数:10
相关论文
共 30 条
[1]   Gene therapy for tissue repair and regeneration [J].
Bonadio, J ;
Goldstein, SA ;
Levy, RJ .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 33 (1-2) :53-69
[2]   Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: Implications for fracture healing [J].
Bouletreau, PJ ;
Warren, SM ;
Spector, JA ;
Peled, ZM ;
Gerrets, RP ;
Greenwald, JA ;
Longaker, MT .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2002, 109 (07) :2384-2397
[3]  
Carlevaro MF, 2000, J CELL SCI, V113, P59
[4]   Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles [J].
Cohen, H ;
Levy, RJ ;
Gao, J ;
Fishbein, I ;
Kousaev, V ;
Sosnowski, S ;
Slomkowski, S ;
Golomb, G .
GENE THERAPY, 2000, 7 (22) :1896-1905
[5]   Regulatory issues for clinical gene therapy trials [J].
Cornetta, K ;
Smith, FO .
HUMAN GENE THERAPY, 2002, 13 (10) :1143-1149
[6]   VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation [J].
Gerber, HP ;
Vu, TH ;
Ryan, AM ;
Kowalski, J ;
Werb, Z ;
Ferrara, N .
NATURE MEDICINE, 1999, 5 (06) :623-628
[7]   Angiogenesis and bone growth [J].
Gerber, HP ;
Ferrara, N .
TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (05) :223-228
[8]  
Hanada K, 2001, J CELL BIOCHEM, V81, P284, DOI 10.1002/1097-4644(20010501)81:2<284::AID-JCB1043>3.0.CO
[9]  
2-D
[10]  
Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.3.CO